April 26, 2023
The legislature of Hawaii this week approved a non-binding resolution encouraging the governor to create a clemency program for prior cannabis convictions.
April 25, 2023
A United Kingdom study revealed an association between cannabis products, improved quality of life, and reduced opioid use in chronic pain patients.
April 24, 2023
The Texas House approved a bill that would allow for more access to the state’s medical cannabis program.
April 17, 2023
Our sister publication, Oncology Nursing News recently published how cannabidiol oil may be useful in helping patients with breast cancer manage tamoxifen-related adverse effects.
April 13, 2023
The Nova Scotia House of Assembly recently heard a petition to cover the cost of CBD-based medications for certain conditions.
April 12, 2023
To help clinicians and patients navigate cannabinoid-based medications (CBM), Cannabis and Cannabinoid Research published guidelines based on reviews of studies on CBM and chronic pain.
April 10, 2023
Two Colorado-based hemp companies and one tobacco company are joining forces to pursue FDA-approval for a new botanical drug.
April 07, 2023
A Washington State House Committee recently amended and then approved a psilocybin bill which will benefit patients.
April 06, 2023
Senate Bill 47, legalizing medical cannabis, was signed into law in March 2023 by Kentucky Governor Andy Beshear (D).
April 05, 2023
Bipartisan legislation was recently reintroduced to remove barriers preventing veterans accessing medical cannabis as recommended by health care providers at the VA.